MedPath

Child outcomes after prenatal progesterone for prevention of preterm birth, follow-up of the AMPHIA trial

Recruiting
Conditions
Prevention of preterm birth in multiple pregnancy
Registration Number
NL-OMON27515
Lead Sponsor
Amsterdam UMC - location AMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

The study population consists of all women that participated in the AMPHIA trial (n=671) and their children (n=1355) between 11-14 years of age.

Exclusion Criteria

Not able to read and speak Dutch and therefore not able to give informed consent and fill out questionnaires for this follow-up study.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognition and behavior of the offspring.
Secondary Outcome Measures
NameTimeMethod
Death (perinatal and death up to 14 years of age), gender identity and health related problems (including information on surgery, hospital admission and medication use).<br>Educational performance at the end of primary school for all children born to women who participated in the AMPHIA trial (regardless of participation in follow-up).
© Copyright 2025. All Rights Reserved by MedPath